XML 49 R38.htm IDEA: XBRL DOCUMENT v3.25.3
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Weighted Average Option Fair Values and Assumptions The assumptions used in determining the fair value of the stock options granted in the respective periods were as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Weighted average fair value of grants
n/a
$49.83$46.74$63.63
Dividend yieldn/a1.42%1.41%1.09%
Volatilityn/a26.47%23.06%26.66%
Risk-free interest raten/a4.08%4.28%4.31%
Expected life (in years)
n/a
4.604.704.60
Schedule of Stock Option Activity
A summary of the Company’s stock option activity as of September 30, 2025 and changes during the nine months ended September 30, 2025 are presented in the following table:
Stock OptionsSharesWeighted
Average
Exercise Price
Weighted-Average
Remaining
Contractual Term (years)
Aggregate
Intrinsic
Value
Outstanding at January 1, 2025998,856 $191.96 6.63$24.9 
Granted82,470 196.07 
Exercised(23,008)133.46 
Forfeited(78,866)212.73 
Outstanding at September 30, 2025979,452 $192.01 6.09$6.1 
Vested and expected to vest as of September 30, 2025963,310 $191.56 6.05$6.1 
Exercisable at September 30, 2025679,799 $181.06 5.18$6.1 
Schedule of Restricted Stock Activity A summary of the Company’s restricted stock activity as of September 30, 2025 and changes during the nine months ended September 30, 2025 are presented in the following table:
Restricted StockSharesWeighted-Average
Grant Date Fair
Value
Unvested at January 1, 2025175,991 $201.27 
Granted100,885 192.07 
Vested(54,709)200.31 
Forfeited(23,482)206.05 
Unvested at September 30, 2025198,685 $196.30 
Schedule of Unvested Cash-settled Restricted Stock Activity A summary of the Company’s unvested cash-settled restricted stock activity as of September 30, 2025 and changes during the nine months ended September 30, 2025 are presented in the following table:
Cash-Settled Restricted StockSharesWeighted-Average
Fair Value
Unvested at January 1, 202555,395 $209.29 
Granted32,090 195.10 
Vested(18,058)187.90 
Forfeited(5,027)162.76 
Unvested at September 30, 202564,400 $162.76 
Schedule of Weighted Average Performance Share Units Fair Values and Assumptions The assumptions used in the Monte Carlo simulation model to determine the fair value of the market condition portion of the performance share units granted in the respective periods were as follows:
 Nine Months Ended September 30,
20252024
Weighted average fair value of grants$232.44$349.59
Dividend yield—%—%
Volatility22.93%22.23%
Risk-free interest rate4.23%4.45%
Expected life (in years)2.942.94
Schedule of Performance Shares Units Activity
A summary of the Company’s performance share unit activity as of September 30, 2025 and changes during the nine months ended September 30, 2025 are presented in the following table:
Performance Share UnitsSharesWeighted-Average
Grant Date Fair
Value
Unvested at January 1, 202572,825 $299.87 
Granted43,360 206.60 
Vested(15,530)234.23 
Forfeited(16,380)254.32 
Unvested at September 30, 202584,275 $270.89 
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs Total compensation cost related to all share-based awards was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Stock options expense$1.0 $1.5 $5.3 $8.4 
Restricted stock expense 3.4 1.6 12.2 5.7
Cash-settled restricted stock expense0.6 1.2 1.8 2.8
Performance share units expense0.5 0.9 6.2 6.8
Total pre-tax share-based compensation expense(1)
5.5 5.2 25.5 23.7
Income tax benefit(0.9)(0.7)(3.3)(2.3)
Total share-based compensation expense, net of income taxes$4.6 $4.5 $22.2 $21.4 

(1) Pre-tax compensation cost is recognized in the Condensed Consolidated Statements of Income depending on the functional area of the underlying employees, as follows:

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Cost of sales$0.3 $0.4 $1.4 $1.4 
Selling, general and administrative expenses5.2 4.8 24.7 22.3
Restructuring expenses and asset impairments(2)
— — (0.6)— 
Total pre-tax share-based compensation expense$5.5 $5.2 $25.5 $23.7 

(2) During the nine months ended September 30, 2025, a benefit of $0.6 million was recognized in Restructuring expenses and asset impairments in the Condensed Consolidated Statements of Income related to forfeitures of share-based compensation awards resulting from previously announced restructuring actions initiated during the first quarter.